Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The normal vascular endothelium and extracellular matrix (ECM) represent the fundamental structural and functional units of the circulatory system. The endothelium is a specialized monolayer of cells that acts as a semi-permeable barrier, regulating the exchange of fluids, nutrients, and cells between the blood and surrounding tissues while maintaining vascular tone and hemostasis (StatPearls, 2023). The ECM provides the essential physical scaffold and biochemical signaling environment, composed of proteins like collagen, elastin, and laminin, which support cellular adhesion and tissue integrity (NCBI, 2022). While not a single molecular target, this complex is a critical focus in pharmacology because it serves as the primary barrier for drug delivery and the site of action for various anticoagulants and anti-angiogenic therapies (PubMed, 2021). Pathological alterations in these structures are central to the progression of atherosclerosis, hypertension, and tumor-associated vascular leakage. Consequently, maintaining the health of the normal endothelium and ECM is a major therapeutic goal in preventing cardiovascular and inflammatory diseases.
Drugs interact with specific molecular components within the endothelium or ECM to modulate vascular permeability, inhibit pathological angiogenesis, regulate blood coagulation, or facilitate tissue penetration.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Normal vascular endothelium and extracellular matrix.